Trials / Terminated
TerminatedNCT00420810
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 138 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is determine whether this drug will improve your insomnia in terms of decreasing your time to fall asleep and allowing you to stay asleep longer. The drug will be compared against placebo in order to determine if there's a difference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0928 / Duration of Treatment : 8 Weeks |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-03-01
- First posted
- 2007-01-11
- Last updated
- 2015-01-14
Source: ClinicalTrials.gov record NCT00420810. Inclusion in this directory is not an endorsement.